| Primary |
| Pain |
30.4% |
| Migraine |
8.9% |
| Leukaemia |
7.1% |
| Supplementation Therapy |
7.1% |
| Back Pain |
5.4% |
| Labour Pain |
5.4% |
| Pain In Extremity |
5.4% |
| Abdominal Pain |
3.6% |
| Anxiety |
3.6% |
| Product Used For Unknown Indication |
3.6% |
| Prophylaxis |
3.6% |
| Blood Pressure |
1.8% |
| Breakthrough Pain |
1.8% |
| Chest Pain |
1.8% |
| Foetal Exposure Timing Unspecified |
1.8% |
| Headache |
1.8% |
| Lung Disorder |
1.8% |
| Musculoskeletal Pain |
1.8% |
| Nephrolithiasis |
1.8% |
| Procedural Pain |
1.8% |
|
| Vomiting |
13.8% |
| Drug Withdrawal Syndrome |
10.3% |
| Drug Abuser |
6.9% |
| Drug Dependence |
6.9% |
| Somnolence |
6.9% |
| Withdrawal Syndrome |
6.9% |
| Convulsion |
3.4% |
| Cyanosis |
3.4% |
| Dizziness |
3.4% |
| Drug Screen Negative |
3.4% |
| Drug Tolerance |
3.4% |
| Feeling Jittery |
3.4% |
| Headache |
3.4% |
| Hypersensitivity |
3.4% |
| Incoherent |
3.4% |
| Injection Site Abscess |
3.4% |
| Mood Disorder Due To A General Medical Condition |
3.4% |
| Muscle Rigidity |
3.4% |
| Myalgia |
3.4% |
| No Therapeutic Response |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
19.1% |
| Pain |
14.9% |
| Drug Use For Unknown Indication |
11.2% |
| Foetal Exposure During Pregnancy |
6.4% |
| Migraine |
5.9% |
| Bipolar I Disorder |
5.3% |
| Hepatitis C |
4.3% |
| Rheumatoid Arthritis |
4.3% |
| Postoperative Analgesia |
3.7% |
| Bone Sarcoma |
3.2% |
| Prophylaxis |
3.2% |
| Headache |
2.7% |
| Supplementation Therapy |
2.7% |
| Arthralgia |
2.1% |
| Chemotherapy |
2.1% |
| Pain In Extremity |
2.1% |
| Sedation |
2.1% |
| Anxiety |
1.6% |
| Back Pain |
1.6% |
| Vitamin Supplementation |
1.6% |
|
| White Blood Cell Count Decreased |
13.3% |
| Drug Hypersensitivity |
11.1% |
| Withdrawal Syndrome |
11.1% |
| Respiratory Failure |
6.7% |
| Tremor |
6.7% |
| Urinary Retention |
6.7% |
| Vomiting |
6.7% |
| Cardiac Failure |
4.4% |
| Leukopenia |
4.4% |
| Somnolence |
4.4% |
| Wrong Technique In Drug Usage Process |
4.4% |
| Injection Site Abscess |
2.2% |
| Injection Site Nodule |
2.2% |
| Intestinal Obstruction |
2.2% |
| Migraine |
2.2% |
| Nausea |
2.2% |
| Pain |
2.2% |
| Paraesthesia |
2.2% |
| Post Procedural Complication |
2.2% |
| Postpartum Depression |
2.2% |
|
| Concomitant |
| Pain |
25.4% |
| Acute Lymphocytic Leukaemia |
10.4% |
| Depression |
7.5% |
| Product Used For Unknown Indication |
6.6% |
| Nausea |
6.1% |
| Headache |
5.2% |
| Drug Use For Unknown Indication |
4.6% |
| Inflammatory Bowel Disease |
4.3% |
| Anticoagulant Therapy |
3.2% |
| Deep Vein Thrombosis |
3.2% |
| Contraception |
2.9% |
| Bone Marrow Transplant |
2.6% |
| Premedication |
2.6% |
| Back Pain |
2.3% |
| Dyspepsia |
2.3% |
| Enterococcal Sepsis |
2.3% |
| Hypertension |
2.3% |
| Acne |
2.0% |
| Migraine |
2.0% |
| Nervousness |
2.0% |
|
| Vomiting |
13.9% |
| White Blood Cell Count Increased |
12.9% |
| Weight Decreased |
8.9% |
| Type 2 Diabetes Mellitus |
7.9% |
| Pain |
5.0% |
| Pulmonary Embolism |
5.0% |
| Toxoplasmosis |
5.0% |
| Weight Gain Poor |
5.0% |
| Anxiety |
4.0% |
| Drug Ineffective |
4.0% |
| Renal Failure Acute |
4.0% |
| Cholecystitis Chronic |
3.0% |
| Osteitis |
3.0% |
| Rectal Haemorrhage |
3.0% |
| Somnolence |
3.0% |
| Stevens-johnson Syndrome |
3.0% |
| Transient Ischaemic Attack |
3.0% |
| Upper Respiratory Tract Infection |
3.0% |
| Deep Vein Thrombosis |
2.0% |
| Diarrhoea |
2.0% |
|
| Interacting |
| Product Used For Unknown Indication |
63.6% |
| Back Pain |
18.2% |
| Diabetes Mellitus |
9.1% |
| Neuropathy Peripheral |
9.1% |
|
| Wrong Technique In Drug Usage Process |
100.0% |
|
